Sponsor content
842 result(s) found, displaying 281 to 290
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA ISOPRENALINE isoprenaline hydrochloride 0.2 mg/1 mL injection solution ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISOCIPRALINE isoprenaline hydrochloride 0.2 mg/1 mL injection solution ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISOCIP isoprenaline hydrochloride 0.2 mg/1 mL injection solution ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISOCIP isoprenaline hydrochloride 1.0 mg/5 mL injection solution ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISOCIPRALINE isoprenaline hydrochloride 1.0 mg/5 mL injection solution ampoule.
-
Australian public assessment report (AusPar)AusPAR for Filpegla (pegfilgrastim) for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia.
-
Australian public assessment report (AusPar)Ardalicip / Ciptunec (adalimumab) for the treatment of arthritis, crohn's disease, ulcerative colitis, psoriasis, uveitis and acne inversa.
-
Prescription medicine registrationActive ingredients: Methotrexate.
-
Australian public assessment report (AusPar)Trastucip and Tuzucip (trastuzumab) for the treatment of breast cancer and gastric cancer
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BEVACIP bevacizumab 100 mg/4 mL concentrated solution for infusion vial.